MONTREAL – Clemex Technologies Inc. announces it has received the TSX Exchange approval and has finalized the strategic alliance with its European partner RAL Diagnostics located in Martillac, France, to whom no previous business links existed. This alliance will notably support the marketing of its new instrument being developed for the Haematology sector. According to […]
Geneva, Switzerland – Goal is to Accelerate Mass Spectrometry-based Biomarker Discovery and its Translation into Development of Routine Clinical Assays (NYSE: TMO) – ThermoFisher.com. Thermo Fisher Scientific Inc., the world leader in serving science, today announced at the Human Proteome Organization (HUPO) 2011 World Congress the establishment of a new Biomarker Translational Center (BT Center). […]
GERMANTOWN, Maryland – QIAGEN today announced that it has entered into a partnership with Eli Lilly and Company for the development, manufacturing and commercialization of a molecular companion diagnostic for an early stage investigational compound currently being developed by Lilly. Financial terms of the agreement were not disclosed. Lilly’s proprietary compound, called a JAK2 inhibitor, […]
IRVINE, Calif. — CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing services for cancer and developmental disorders, today announced that diagnostics industry veteran Jeff Hayes has been named Director of Sales for the Oncology market. Hayes brings more than 20 years of experience in the biopharmaceutical and cancer diagnostics industries to the position, […]
LINCOLN, Neb.–LI-COR Biosciences announces an Active Substance Master File (ASMF) for IRDye 800CW N-succidimidyl ester is on record with European regulatory authorities in support of a clinical trial testing a targeted agent for optical imaging-assisted surgery. In addition, a Drug Master File has been registered with the United States Food and Drug Administration in anticipation […]
JEOL Ltd. (Tokyo, President: Gon-enon Kurihara) and Siemens Healthcare Diagnostics Inc.?Tarrytown, NY, CEO: Michael Reitermann?have signed a new 10-year contract, reinforcing a longstanding relationship and creating a more robust partnership. With approximately 5% growth worldwide in 2010FY, the clinical chemistry market is steadily expanding. To keep abreast of the market and with the escalation of […]
LONGUEUIL, QUEBEC – The Honourable Denis Lebel, Minister of Transport, Infrastructure and Communities and Minister of the Economic Development Agency of Canada for the Regions of Quebec, today announced that Clemex Technologies Inc. has been granted $106,300 in repayable funding to carry out a commercialization project. “Investing in the knowledge economy is a priority for […]
TUCSON, Ariz.––HTG Molecular Diagnostics today announced the availability of the qDiscovery miRNA Whole Transcriptome Array (WTA) Version 16, a complete solution for microRNA (miRNA) analysis on any sample type or size. This array is an update to the previous Version 11 which measures all known human, rat and mouse miRNA in a single sample well […]
VENLO, The Netherlands and MELBOURNE, Australia, QIAGEN N.V. today announced that its acquisition of all the ordinary shares in Cellestis Limited (“Cellestis”) by a way of a scheme of arrangement (“Scheme”) has been implemented. The closing of the transaction follows the official approval of Cellestis’ shareholders and Australian courts. QIAGEN had announced the initial proposal […]
Bioscience, Inc. today provided the financial community with guidance regarding the Company’s fiscal 2012 sales and earnings estimates. Based on the Company’s business planning and budgeting activities for the fiscal year ending September 30, 2012, management expects net sales to be in the range of $183 to $192 million and per share diluted earnings to […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
